Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 18, 2011Journal of Viral HepatitisOpen Access

Economic burden of hepatitis C‐associated diseases in the United States

View Full Paper
Ask AI
Bookmark
Share

Authors

AKAntoine C. El KhouryJohnson & Johnson (United States)WKWilliam K. KlimackUniversity of OklahomaCWCarolyn WallaceCincinnati Children's Hospital Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Khoury et al. (2011) studied this question.

synapsesocial.com/papers/6a0152360acff741bf7732afhttps://doi.org/10.1111/j.1365-2893.2011.01563.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Costs of Hepatitis C2001 · 106 citations
  2. 2Cost effectiveness of interferon α2b combined with ribavirin for the treatment of chronic hepatitis C1999 · 162 citations
  3. 3Direct Economic Burden of Chronic Hepatitis C Virus in a United States Managed Care Population2010 · 139 citations
  4. 4Cost of Liver Transplantation2008 · 62 citations
  5. 5Payer status, but not race, affects the cost of liver transplantation1998 · 27 citations